Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01327521
Show Display Options
Rank Status Study
1 Withdrawn Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Device: CyberKnife;   Procedure: TACE;   Drug: CT Contrast;   Drug: doxorubicin;   Drug: Epirubicin;   Drug: 5-fluorouracil;   Drug: Mitomycin C;   Drug: Gemcitabine;   Drug: Cisplatin;   Device: SMANCS

Study has passed its completion date and status has not been verified in more than two years.